HOUSTON, July 30,
2024 /PRNewswire/ -- The American Society for
Preventive Cardiology (ASPC) previously announced the development
of a 2-year fellowship program to support the creation of
cardiometabolic training programs nationwide and increase the
number of expert clinicians equipped to effectively manage patients
with cardiometabolic risk factors. The ASPC is pleased to announce
that the world-renowned Johns Hopkins Ciccarone Center for the
Prevention of Cardiovascular Disease will host the first ASPC
Cardiometabolic Medicine Fellow. Dr. Yara Jelwan started her
training on July 1, 2024 with Dr.
Michael Blaha as program
director.
Dr. Jelwan studied at the Lebanese American
University in Beirut, continued her education receiving an
MPH in methodology and statistics in Paris, and is currently a Post-Graduate Year 3
Internal Medicine resident at St. Lukes Hospital in St. Louis. Dr. Jelwan's notable work at St.
Luke's Hospital includes enhancing Coronary Artery Calcium scoring
and addressing the underutilization of SGLT2 inhibitors and GLP1
receptor agonists.
"Thank you to the ASPC for this wonderful opportunity!" Dr.
Jelwan stated. "I am excited to be a part of a new tradition of
cardiometabolic training within preventive cardiology."
The rate of metabolic diseases – obesity, metabolic syndrome,
diabetes mellitus – have been steadily increasing in the United States and across the globe. In
2019, of the 37 million people in the U.S. who were estimated to
have diabetes, nearly 25% of them were undiagnosed, and the total
number is expected to triple by 2060.1,2 The number of
U.S. adults in 2020 with obesity and severe obesity are projected
to increase from 42% to 50% and 18% to 25% respectively in
2030.3 The rate of metabolic syndrome has increased 25%
from 1988 to 2012, representing a third of the U.S.
population.4
Historically, the care of cardiometabolic diseases has been
fragmented between primary care physicians and specialists such as
endocrinologists, cardiologists, and less often hepatologists and
nephrologists.5 This approach has been characterized by
sparse interaction among specialists and lack of ownership of the
field by any specialty or type of physician. As a result, the
cardiometabolic patient is left without a "home", instead being
shuffled between specialty clinics.
"There is a recognition that we are undertreating
cardiometabolic disease in our high-risk cardiovascular patients,"
Dr. Blaha commented. "This is an important step toward our vision
of more widespread cardiometabolic medicine training in the
U.S.".
The ASPC is a non-profit membership-based association dedicated
to educating health care professionals and patients about the
prevention of cardiovascular diseases. For more information about
ASPC, please visit www.aspconline.org.
References:
-
https://www.cdc.gov/diabetes/data/statistics-report/diagnosed-undiagnosed-diabetes.html
- Lin J, et al. Projection of the future diabetes burden in
the United States through 2060.
Popul Health Metr. 2018 Jun 15;16(1):9.
- Ward ZJ, et al. Projected U.S. State-Level Prevalence of Adult
Obesity and Severe Obesity. N Engl J Med. 2019 Dec
19;381(25):2440-2450.
-
https://www.cdc.gov/pcd/issues/2017/testimplementationevalxml.htm#contribAff
- Saxon DR, et al. Cardiometabolic Medicine: Development of a New
Subspecialty. J Clin Endocrinol Metab. 2020 Jul 1;105(7).
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aspc-makes-selection-for-the-first-cardiometabolic-medicine-fellowship-training-302221244.html
SOURCE The American Society for Preventive Cardiology